Fertility preservation and reproduction in patients facing gonadotoxic therapies: an Ethics Committee opinion

Chemotherapy and radiation therapy often result in reduced fertility. Patients receiving gonadotoxic treatment should be informed of options for fertility preservation and future reproduction prior to such treatment. Reproduction in the context of cancer also raises a number of ethical issues related to the welfare of both patients and offspring. This document replaces the document titled, Fertility preservation and reproduction in patients facing goandotoxic therapies, last published in 2013. (C) 2018 by American Society for Reproductive Medicine.